Direct Vocal Fold Testosterone Injection for Treatment of Sulcus Vocalis: A Case Report
Abstract
This case report describes the use of targeted vocal fold testosterone injection as a novel, minimally invasive treatment for sulcus vocalis in a 28-year-old cisgender male with long-standing voice difficulties unresponsive to conventional therapies. He underwent two intramuscular testosterone injections into the thyroarytenoid muscle. Post-treatment, he demonstrated significant vocal improvements, including enhanced glottal competence, increased phonation time, and improved patient-reported outcomes, suggesting that androgen receptor stimulation may promote vocal fold remodeling as a potential alternative to surgical intervention.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Induced osteoblast differentiation by amide derivatives of stilbene: The possible osteogenic agents
- On model selections for repeated measurement data in clinical studies
- Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells
- Region-specific microRNA signatures in the human epididymis
- Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety
- In Vitro characterization of the endocrine disrupting effects of per- and poly-fluoroalkyl substances (PFASs) on the human androgen receptor
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.